| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.9B | $18.5B | $17.5B | $16.3B | $14.6B | $4.5B | $4.0B | $3.6B |
| Cost of Revenue | $9.0B | $8.7B | $8.4B | $7.8B | $6.9B | $5.9B | $5.5B | $5.2B |
| Gross Profit | $10.0B | $9.8B | $9.1B | $8.5B | $7.7B | $2.4B | $2.1B | $1.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $6.4B | $6.0B | $5.6B | $5.2B | $4.8B | $4.4B | $4.1B | $4.2B |
| Operating Income | $3.6B | $3.8B | $3.5B | $3.3B | $2.9B | $1.0B | $0.8B | $0.6B |
| Net Income | $2.5B | $2.7B | $2.5B | $2.4B | $2.2B | $0.7B | $0.6B | $0.4B |
| EPS (Basic) | $148.80 | $153.82 | $136.60 | $120.83 | $97.60 | $31.67 | $23.15 | $15.27 |
| EPS (Diluted) | $144.87 | $149.55 | $132.36 | $117.19 | $95.19 | $30.93 | $22.59 | $15.02 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $19.4B | $17.2B | $16.0B | $15.3B | $14.5B | $14.4B | $9.9B | $9.3B |
| Current Assets | $8.3B | $7.3B | $6.8B | $6.6B | $6.4B | $6.8B | $5.0B | $4.6B |
| Cash & Equivalents | $0.3B | $0.3B | $0.3B | $0.3B | $1.2B | $1.8B | $0.2B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $9.5B | $8.7B | $8.5B | $8.6B | $7.4B | $6.3B | $5.5B | $5.0B |
| Stockholders' Equity | $-3.4B | $-4.7B | $-4.3B | $-3.5B | $-1.8B | $-0.9B | $-1.7B | $-1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.1B | $3.0B | $2.9B | $3.2B | $3.5B | $2.7B | $2.1B | $2.1B |
| Investing Cash Flow | $-1.4B | $-1.3B | $-0.9B | $-0.6B | $-0.6B | $-0.5B | $-0.5B | $-0.5B |
| Capital Expenditures | $1.3B | $1.1B | $0.8B | $0.7B | $0.6B | $0.5B | $0.5B | $0.5B |
| Financing Cash Flow | $-1.7B | $-1.7B | $-2.1B | $-3.5B | $-3.5B | $-0.6B | $-1.7B | $-1.6B |